Nellcor™ Investigational Device Sitting-Walking Study
Medtronic - MITG · NCT07234279
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- August 11, 2026
- Record last updated
- October 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To examine pulse rate and blood oxygen saturation accuracy of the Nellcor™ Investigational Device during non-motion and walking motion conditions in a diverse patient population through non-invasive means
Conditions: Oxygen Saturation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male or female participants ≥18 years of age, and \<75 years of age.
- Participant is able to participate for the duration of the study
- Participant is willing to sign an informed consent form (ICF)
- Participant weighs > 40kg
- Participants must be a non-smoker or not have smoked within 36 hours prior to the study
Exclusion Criteria
- Participant self-reported prior injury or trauma to fingers or hands, which in the opinion of the investigator, may change blood flow or vascular supply and affect the ability to test sensors
- Physiologic abnormalities that prevent proper application of pulse oximetry sensor
- Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes
- Individuals of childbearing potential who are self-reported as pregnant, or who are self-reported as trying to get pregnant
- Morbid obesity (defined as BMI > 39.5)
- Weight > 136 kg
- Participants who self-report problems of unsteadiness or imbalance issues and/or who are unable to walk on a treadmill without holding onto the handrails
- Participant self-reported known heart or cardiovascular conditions such as:
- Uncontrolled hypertension (Systolic pressure ≥ 140mmHg or Diastolic pressure > 90mmHg on 3 consecutive readings day of screening)
- Heart arrhythmias other than sinus arrhythmia (Self-reported and/or as identified on ECG day of screening).
- History of heart attack, blocked artery, history of myocardial ischemia, angina, myocardial infarction, congestive heart failure, cardiomyopathy, stroke, transient ischemic attack, or carotid artery disease
- Participants with self-reported clotting disorders, such as:
- History of bleeding disorders or personal history of prolonged bleeding from injury
- History of blood clots
- Hemophilia
- Current use of prescription blood thinner
- Participants with other self-reported, known health conditions, such as:
- Diabetes
- Thyroid disease
- Kidney disease / chronic renal impairment
- History of seizures (except childhood febrile seizures), epilepsy, or unexplained syncope
- Recent history of frequent migraine headaches, as determined medically relevant by the PI
- History of head injury, as determined medically relevant by the PI
- Cancer / chemotherapy
- Sickle cell disease
- History of hospital admission or a surgical procedure in the 60 days prior to study enrollment (self-reported)
- Participants with any contraindications to protocol specific repositioning techniques
- Unwillingness or inability to remove colored nail polish from test digit(s)
- Participants who have self-reported health conditions beyond what is captured in the prior exclusion criteria, which in the opinion of the Investigator and/or Clinical Staff would classify the participant as medically unsuitable
Recruiting US locations
Clinical Physiology Lab
Denver, CO 80217
Site contact: Clinical Research Manager · 303-570-1721 · roger.martin-pressman@medtronic.com
Study contacts (from the official record)
- Hannah Bowman · 720-930-1695 · Hannah.bowman@medtronic.com
- Ami Stuart · ami.stuart@medtronic.com
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100